Vivani Medical, Inc. filed a Form 8-K on October 29, 2026, under Item 7.01 (Regulation FD Disclosure) to furnish an investor slide presentation distributed to the investment community at industry and other conferences.

Key Highlights

  • Filing date: October 29, 2026, with the date of the earliest event reported also October 29, 2026.
  • Disclosure type: The filing was made under Item 7.01, Regulation FD Disclosure.
  • Exhibit 99.1: A slide presentation dated October 29, 2026, was attached and incorporated by reference.
  • Non-filed status: According to the filing, the information in Item 7.01 and Exhibit 99.1 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934."
  • Signatory: The report was signed by Donald Dwyer, Chief Business Officer of Vivani Medical, Inc.
  • No update obligation: The company "specifically disclaims any obligation" to update the slide presentation, according to the filing.

Vivani Medical Furnishes Conference Slide Presentation Under Regulation FD

Vivani Medical, Inc. (NASDAQ:VANI), a Delaware corporation headquartered at 1350 S. Loop Road, Alameda, California 94502, submitted a current report on October 29, 2026, disclosing that it from time to time presents or distributes slide presentations to the investment community at various industry and other conferences. The company stated that the filing was made to provide "updates and summaries of its business," according to the report.

The slide presentation, designated as Exhibit 99.1 and dated October 29, 2026, was attached to the filing and incorporated by reference. The filing noted that the presentation "speaks only as of the date of this Current Report on Form 8-K." While the company indicated it may elect to update the presentation in the future, it explicitly disclaimed any obligation to do so.

The filing clarified that the content furnished under Item 7.01 and in Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities under that section. The filing further stated the information shall not be incorporated by reference into any Securities Act or Exchange Act filing unless expressly set forth in such a filing. The report was signed by Donald Dwyer in his capacity as Chief Business Officer.

What Was Disclosed

Vivani Medical furnished an investor slide presentation dated October 29, 2026, under Regulation FD, attached as Exhibit 99.1. The materials are not deemed "filed" under the Exchange Act and carry no company obligation for future updates.